ロード中...
Androgen receptor decoy molecules block the growth of prostate cancer
The androgen receptor (AR) is activated by both ligand-dependent and -independent mechanisms. Current therapies for prostate cancer target the ligand-binding domain in the C terminus of the AR. However, ligand-independent activation of the AR occurs by the N-terminal domain (NTD), making the NTD a p...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
National Academy of Sciences
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1783142/ https://ncbi.nlm.nih.gov/pubmed/17227854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0606718104 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|